First human tests of new hepatitis b vaccines show early safety data
NCT ID NCT05770895
Summary
This early-stage study tested the safety of two experimental therapeutic vaccines (GS-2829 and GS-6779) designed to treat chronic hepatitis B. The study involved 83 participants, including both healthy volunteers and people with stable, well-controlled hepatitis B infection. The main goal was to check for side effects and see if the vaccines could stimulate an immune response against the hepatitis B virus in infected participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chang Gung Medical Foundation Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 833, Taiwan
-
Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital
Taoyuan, 33305, Taiwan
-
Chia-Yi Christian Hospital
Chiayi City, 60002, Taiwan
-
E-DA Hospital
Kaohsiung City, 82445, Taiwan
-
Kaohsiung Medical University Hospital
Kaohsiung City, 807, Taiwan
-
National Cheng Kung University Hospital
Tainan, 7428, Taiwan
-
National Taiwan University Hospital
Taipei, 100229, Taiwan
-
New Zealand Clinical Research (NZCR)
Auckland, 1010, New Zealand
-
St. Martin De Porres Hospital
Chiayi City, 600, Taiwan
Conditions
Explore the condition pages connected to this study.